Showing results (381-390 of 442) with videos related to
Sort By:
Pageof 45
Acta Anaesthesiologica Scandinavica|April 16, 2002
Double-blind comparison of the variability in spontaneous recovery of cisatracurium- and vecuronium-induced neuromuscular block in adult and elderly patientsF K Pühringer, T Heier, M Dodgson, et al.The New England Journal of Medicine|November 14, 1997
A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacementB I Eriksson, P Wille-Jørgensen, P Kälebo, et al.Journal of Thrombosis and Haemostasis : JTH|January 22, 2010
Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2)B I Eriksson, A G G Turpie, M R Lassen, et al.Annals of Neurology|December 23, 2011
Resolving postoperative neuroinflammation and cognitive declineNiccolò Terrando, Lars I Eriksson, Jae Kyu Ryu, et al.Frontiers in Endocrinology|June 16, 2023
Atrophy of the optic chiasm is associated with microvascular diabetic complications in type 1 diabetesAleksi Tarkkonen, Tor-Björn Claesson, Marika I Eriksson, et al.Thrombosis and Haemostasis|September 4, 2008
Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacementWolfgang Mueck, Lars C Borris, Ola E Dahl, et al.Acta Diabetologica|November 18, 2025
Characteristics of above 65-year-olds with type 1 diabetes in the Finnish diabetic nephropathy studyEmilia M C Franzén, Marika I Eriksson, Susanna Satuli-Autere, et al.Anesthesiology|August 13, 2019
Upper Airway Collapsibility during Dexmedetomidine and Propofol Sedation in Healthy Volunteers: A Nonblinded Randomized Crossover StudyÅse Lodenius, Kathleen J Maddison, Brad K Lawther, et al.Circulation|November 23, 2006
A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacementBengt I Eriksson, Lars C Borris, Ola E Dahl, et al.Lancet (London, England)|June 28, 2008
Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trialAjay K Kakkar, Benjamin Brenner, Ola E Dahl, et al.Pageof 45